{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "EU ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT04111484: Not Applicable Interventional Completed Headache, Migraine
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:dafsolimab setaritox [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04627025: Phase 3 Interventional Completed Short Bowel Syndrome
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02605525: Phase 2 Interventional Withdrawn Immunoglobulin A Nephropathy
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03902184: Phase 2 Interventional Active, not recruiting Lymphoma, T-Cell
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03867682: Phase 1/Phase 2 Interventional Recruiting Acute Myeloid Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03588026: Phase 3 Interventional Completed Paroxysmal Nocturnal Hemoglobinuria (PNH)
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01480479: Phase 3 Interventional Completed Glioblastoma
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03943589: Phase 2 Interventional Completed Guillain-Barré Syndrome (GBS)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01081691: Phase 1 Interventional Completed Healthy
(2010)
Source URL:
Class:
PROTEIN
